| Hans-Günter Meyer-Thompson | International
Europa. EMCDDA Strategy 2025
This strategy sets out an ambitious course of travel for the agency to 2025. It presents a vision to contribute to a healthier and more secure Europe, through better informed drug policy and action. Adopted unanimously by the agency’s key stakeholders in 2016, the strategy is the result of a year-long, in-depth analysis of the environment in which the EMCDDA operates. This analysis focused, in particular, on customer needs and a critical review of our internal capacity to meet them. (EMCDDA, Lissabon, März 2017)
http://www.emcdda.europa.eu/publications/work-programmes-and-strategies/strategy-2025